Physician

Anis A Rauf, DO

According to 2025 Medicare claims, Anis Rauf, DO (NPI: 1639259740) practices critical care (intensivists) in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Du Page, IL. This provider's primary affiliated billing organization is NANI ELK GROVE (NPI: 1154675528; TIN: 460776648) and primary practice location at 60521-3829. Rauf is affiliated with the Accountable Care Organization of Advocate Aurora Health, LLC (ACO ID: D0260), participating under the REACH model.

Rauf's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 609 traditional Medicare patients, billed 2,049 HCPCS/CPT codes, and received $221,365 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,438 prescription claims across 208 beneficiaries totaling $1,414,754 in drug costs, led by Cortrophin (Corticotropin). DME data shows 41 claims. Open Payments data shows 179 records totaling $93,906. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $312,537 and ending at $1,414,754. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	979	3,413	$350,222
2016	833	2,849	$295,212
2017	853	3,143	$314,571
2018	797	2,694	$290,794
2019	828	2,828	$306,367
2020	688	2,698	$274,807
2021	630	2,816	$288,044
2022	617	2,610	$277,445
2023	615	2,397	$249,181
2024	609	2,049	$221,365

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	349	2,424	$312,537
2016	294	2,161	$539,197
2017	318	2,069	$528,402
2018	308	2,186	$302,877
2019	275	1,743	$194,628
2020	240	1,495	$299,502
2021	227	1,672	$352,541
2022	235	1,693	$503,903
2023	228	1,605	$681,993
2024	208	1,438	$1,414,754

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	37	$1,628
2024	N/R	41	$1,132

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	189	230	$139
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	210	546	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	159	232	$71
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	157	328	$63
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	89	96	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cortrophin	Corticotropin	14	479	$893,336
Thiola Ec	Tiopronin	13	390	$103,371
Rayaldee	Calcifediol	37	1,590	$64,435
Farxiga	Dapagliflozin Propanediol	50	3,105	$57,257
Xphozah	Tenapanor Hcl	13	510	$47,172

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	12	$636
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	17	$288
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	12	$207

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	179	$93,906	CALLIDITAS THERAPEUTICS US INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anis A. Rauf, DO?

Tedicare shows public-source Medicare data for Anis A. Rauf, DO (NPI 1639259740), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anis A. Rauf, DO have ACO affiliation data?

Anis A. Rauf, DO is shown with ACO affiliation data for Accountable Care Organization of Advocate Aurora Health, LLC (REACH, ACO ID D0260).

What billing organization is linked to Anis A. Rauf, DO?

Anis A. Rauf, DO is linked to NANI ELK GROVE (billing NPI 1154675528) in the available physician profile data.

Does Anis A. Rauf, DO have Open Payments data?

Anis A. Rauf, DO has 179 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.